54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 06
17:31 UTC
|
CHYM
Chime Financial
|
◎ Target | Patrick Moley ★★★☆☆ #1855 | Overweight | $30.00→ $35.00+16.7% |
|
Aug 06
17:31 UTC
|
CHCT
Community Healthcare Trust
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1105 | Neutral | $20.00→ $17.00-15.0% |
|
Aug 06
17:31 UTC
|
CAVA
CAVA Group
|
◎ Target | Logan Reich ★★★★☆ #970 | Outperform | $105.00→ $90.00-14.3% |
|
Aug 06
17:31 UTC
|
CARL
Carlsmed
|
◎ Target | Richard Newitter ★★★★☆ #460 | Buy | $18.00→ $20.00+11.1% |
|
Aug 06
17:31 UTC
|
BV
BrightView
|
◎ Target | Toni Kaplan ★★★★☆ #542 | Equal Weight | $14.00→ $12.50-10.7% |
|
Aug 06
17:31 UTC
|
BROS
Dutch Bros
|
◎ Target | Logan Reich ★★★★☆ #970 | Outperform | $75.00→ $70.00-6.7% |
|
Aug 06
17:31 UTC
|
BR
Broadridge Financial Solutions
|
◎ Target | James Faucette ★★★☆☆ #1134 | Equal Weight | $169.00→ $176.00+4.1% |
|
Aug 06
17:31 UTC
|
BCRX
BioCryst Pharmaceuticals
|
◎ Target | Brian Abrahams ★★★☆☆ #2227 | Outperform | $14.00→ $13.00-7.1% |
|
Aug 06
17:31 UTC
|
AXON
Axon Enterprise
|
◎ Target | James Fish ★★★☆☆ #1704 | Overweight | $724.00→ $732.00+1.1% |
|
Aug 06
17:31 UTC
|
AVT
Avnet
|
◎ Target | William Stein ★★☆☆☆ #2647 | Buy | $95.00→ $110.00+15.8% |
|
Aug 06
17:31 UTC
|
ASH
Ashland
|
◎ Target | Steven Haynes ★★★☆☆ #1267 | Equal Weight | $58.00→ $78.00+34.5% |
|
Aug 06
17:31 UTC
|
APP
AppLovin
|
◎ Target | Alicia Reese ★★★☆☆ #1686 | Outperform | $640.00→ $610.00-4.7% |
|
Aug 06
17:31 UTC
|
APP
AppLovin
|
◎ Target | Matthew Swanson ★★★☆☆ #1014 | Outperform | $700.00→ $575.00-17.9% |
|
Aug 06
17:31 UTC
|
APP
AppLovin
|
◎ Target | Matthew Cost ★★☆☆☆ #2372 | Overweight | $720.00→ $650.00-9.7% |
|
Aug 06
17:31 UTC
|
APLD
Applied Digital
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3160 | Equal Weight | $36.50→ $37.50+2.7% |
|
Aug 06
17:31 UTC
|
APD
Air Products and Chemicals
|
◎ Target | Arun Viswanathan ★★★☆☆ #1251 | Outperform | $358.00→ $360.00+0.6% |
|
Aug 06
17:31 UTC
|
AMGN
Amgen
|
◎ Target | Courtney Breen ★★★★★ #26 | Market Perform | $335.00→ $345.00+3.0% |
|
Aug 06
17:31 UTC
|
AMD
Advanced Micro Devices
|
◎ Target | Jim Kelleher ★★★☆☆ #1076 | Buy | $450.00→ $625.00+38.9% |
|
Aug 06
17:31 UTC
|
AIZ
Assurant
|
◎ Target | Paul Newsome ★★★★★ #140 | Overweight | $290.00→ $329.00+13.4% |
|
Aug 06
17:31 UTC
|
AIZ
Assurant
|
◎ Target | Mark Hughes ★★★★☆ #715 | Buy | $310.00→ $355.00+14.5% |
|
Aug 06
17:31 UTC
|
AHCO
AdaptHealth
|
◎ Target | Ben Hendrix ★★★★☆ #740 | Outperform | $15.00→ $8.00-46.7% |
|
Aug 06
17:31 UTC
|
ADV
Advantage Solutions
|
◎ Target | Toni Kaplan ★★★★☆ #542 | Equal Weight | $35.00→ $34.00-2.9% |
|
Aug 06
17:31 UTC
|
ZG
Zillow Group
|
↓ Downgrade | Nikhil Devnani ★★★★☆ #430 | Outperform→ Market Perform | $50.00→ $38.00-24.0% |
|
Aug 06
17:31 UTC
|
HUBS
HubSpot
|
↓ Downgrade | Alex Zukin ★☆☆☆☆ #3153 | Outperform→ Peer Perform | |
|
Aug 06
17:31 UTC
|
HUBS
HubSpot
|
↓ Downgrade | Firoz Valliji not yet tracked | Outperform→ Market Perform | $381.00→ $220.00-42.3% |
|
Aug 06
17:31 UTC
|
EPAM
EPAM Systems
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Aug 06
17:31 UTC
|
CRTO
Criteo
|
↓ Downgrade | Mark Zgutowicz ★★☆☆☆ #2616 | Outperform→ Market Perform | $35.00→ $20.50-41.4% |
|
Aug 06
17:31 UTC
|
APP
AppLovin
|
↓ Downgrade | James Callahan not yet tracked | Overweight→ Neutral | $665.00→ $385.00-42.1% |
|
Aug 06
17:31 UTC
|
MDU
MDU Resources Group
|
↑ Upgrade | Aidan Kelly ★★★☆☆ #1319 | Neutral→ Overweight | $27.00 |
|
Aug 06
17:31 UTC
|
GPN
Global Payments
|
↑ Upgrade | Darrin Peller ★★★☆☆ #1496 | Peer Perform→ Outperform | $110.00 |
|
Aug 06
16:31 UTC
|
XNCR
Xencor
|
◎ Target | David Nierengarten ★★☆☆☆ #2467 | Outperform | $26.00→ $30.00+15.4% |
|
Aug 06
16:31 UTC
|
TTMI
TTM Technologies
|
◎ Target | William Stein ★★☆☆☆ #2647 | Buy | $215.00→ $224.00+4.2% |
|
Aug 06
16:31 UTC
|
SST
System1
|
◎ Target | Daniel L. Kurnos not yet tracked | Buy | $8.00→ $6.50-18.8% |
|
Aug 06
16:31 UTC
|
SOLV
Solventum
|
◎ Target | Michael Piccolo ★★☆☆☆ #2894 | Outperform | $94.00→ $101.00+7.4% |
|
Aug 06
16:31 UTC
|
SKWD
Skyward Specialty Insurance Group
|
◎ Target | Mark Hughes ★★★★☆ #715 | Buy | $70.00→ $75.00+7.1% |
|
Aug 06
16:31 UTC
|
SHOP
Shopify
|
◎ Target | Ygal Arounian ★★★☆☆ #2067 | Outperform | $155.00→ $176.00+13.5% |
|
Aug 06
16:31 UTC
|
RCUS
Arcus Biosciences
|
◎ Target | Robert Driscoll ★★☆☆☆ #2344 | Outperform | $41.00→ $43.00+4.9% |
|
Aug 06
16:31 UTC
|
PODD
Insulet
|
◎ Target | Bruce D. Jackson not yet tracked | Buy | $250.00→ $185.00-26.0% |
|
Aug 06
16:31 UTC
|
PACS
PACS Group
|
◎ Target | David MacDonald not yet tracked | Buy | $52.00→ $62.00+19.2% |
|
Aug 06
16:31 UTC
|
ONC
BeOne Medicines
|
◎ Target | Gregory Renza ★★★☆☆ #1227 | Buy | $416.00→ $418.00+0.5% |
|
Aug 06
16:31 UTC
|
OC
Owens Corning
|
◎ Target | Keith Hughes ★★★☆☆ #1642 | Hold | $125.00→ $140.00+12.0% |
|
Aug 06
16:31 UTC
|
MGNI
Magnite
|
◎ Target | Daniel L. Kurnos not yet tracked | Buy | $30.00→ $33.00+10.0% |
|
Aug 06
16:31 UTC
|
METC
Ramaco Resources
|
◎ Target | Nathan P. Martin not yet tracked | Buy | $38.00→ $26.00-31.6% |
|
Aug 06
16:31 UTC
|
MDLN
Medline
|
◎ Target | Jailendra Singh ★★★★★ #174 | Buy | $56.00→ $47.00-16.1% |
|
Aug 06
16:31 UTC
|
LPX
Louisiana-Pacific
|
◎ Target | Michael Roxland ★★★☆☆ #1205 | Buy | $91.00→ $89.00-2.2% |
|
Aug 06
16:31 UTC
|
IFF
International Flavors & Fragrances
|
◎ Target | Ben Klieve ★☆☆☆☆ #3142 | Buy | $100.00→ $105.00+5.0% |
|
Aug 06
16:31 UTC
|
IEX
IDEX
|
◎ Target | John Eade ★★★★☆ #865 | Buy | $250.00→ $260.00+4.0% |
|
Aug 06
16:31 UTC
|
EXPE
Expedia Group
|
◎ Target | Daniel L. Kurnos not yet tracked | Buy | $290.00→ $360.00+24.1% |
|
Aug 06
16:31 UTC
|
EOG
EOG Resources
|
◎ Target | Gabe Daoud not yet tracked | Hold | $134.00→ $153.00+14.2% |
|
Aug 06
16:31 UTC
|
ECPG
Encore Capital Group
|
◎ Target | Mark Hughes ★★★★☆ #715 | Buy | $105.00→ $112.00+6.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.